Atorvstatin Calcium Tablets — Class III drug recall D-0726-2022
Terminated recall by Dr. Reddy's Laboratories, Inc., reported 2022-04-06, distributed nationwide. Failed Impurities/Degradation Specifications: Out of Specification results for related substance.
| Recall number | D-0726-2022 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Dr. Reddy's Laboratories, Inc., Princeton, NJ, United States |
| Recall initiated | 2022-03-16 |
| Classified | 2022-03-29 |
| Reported by FDA | 2022-04-06 |
| Terminated | 2023-11-13 |
| Distributed | Nationwide (US) |
| Quantity | 28,068 bottles |
| Reason classes | specification failure |
| NDC | 55111-0124, 55111-0124-05, 55111-0124-30, 55111-0124-60, 55111-0124-90 |
| Lot numbers | T000707, T000756, T000758, T000759, T2100600, T2101075, T2102802 |
| Expiration dates | 2022-03, 2023-01, 2023-07 |
Product
Atorvstatin Calcium Tablets, USP 80 mg*, 90 Tablets, Rx Only, Mrd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, INDIA, NDC 55111-124-90
Reason for recall
Failed Impurities/Degradation Specifications: Out of Specification results for related substance.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0726-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.